FCA
OGN icon

Fortis Capital Advisors’s Organon & Co OGN Stock Holding History

Fortis Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18
Closed -$423 – 453
2023
Q1 		$423 Hold
18
– – ﹤0.01% 629
2022
Q4 		$503 Buy
+18
New +$460 ﹤0.01% 631

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Fortis Capital Advisors's OGN Position: Q2 2023 in Review

Fortis Capital Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 18 shares — an estimated $423 sold.

Fortis Capital Advisors first reported a position in OGN in Q4 2022 and held it in 2 quarters. The position peaked at $503 in Q4 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Fortis Capital Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Fortis Capital Advisors sold 18 Organon & Co shares in Q2 2023, an estimated $423.
  • Fortis Capital Advisors first reported a position in Organon & Co in Q4 2022 and held it in 2 quarters.
  • Fortis Capital Advisors's Organon & Co position peaked at $503 in Q4 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Fortis Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.